Case Report #5 – From Pain Relief to Better Energy: 30 Days with NanoVi Exo® in a 60-Year-Old Woman

Highlights

  • Better sleep and emotional balance. Within two weeks of daily NanoVi Exo® sessions, sleep quality improved by over 80%, and both stress and depression resolved completely, remaining stable through day 30.
  • Pain relief and physical gains. Pain scores dropped by more than 50%, while physical function and social participation increased, pointing to enhanced daily comfort and activity.
  • Sharper brain oxygenation and autonomic balance. Parasympathetic activity rose (+10%) as sympathetic activity declined (–9%), and brain oxygenation more than doubled (+110%), reflecting improved physiological regulation.
  • Stronger mitochondrial performance. Bioenergetic tests showed dramatic improvements — mitochondrial membrane potential (+305%), network integrity (+195%), and efficiency (+12%) — suggesting more efficient cellular energy production.

 

Could daily 20-minute sessions with a wellness device improve sleep, reduce pain, and boost mitochondrial performance?
This case study suggests it might be possible. Over 30 days, a 60-year-old woman (“M.T.”) experienced significant physical and physiological changes after using the NanoVi Exo®.

What is the NanoVi Exo®?

The NanoVi Exo® is designed to help counteract oxidative stress and support cellular repair by delivering “activated” humidified air. This approach aims to improve recovery, balance the nervous system, and enhance overall well-being.

The Participant & Protocol

  • Age: 60 years
  • Routine: 20 minutes daily with the NanoVi Exo® for 30 days
  • Assessments:
    • Questionnaires: MOS Sleep Scale, DASS-21, PROMIS-29 at baseline, day 15, and day 30
    • Physiological Measures: PPG Stress Flow and HEG (Biotekna, Italy) at baseline and day 30
    • Mitochondrial Function Tests: mescreen™ bioenergetic and redox assessments


💤
Sleep Quality Improved

By the halfway point, M.T. was already sleeping better:

  • Index I: ↓ 58% at day 15, reaching complete resolution by day 30
  • Index II: ↓ 54% at day 15, ↓ 85% by day 30


😊 Mood & Stress Changes

  • Depression: Fully resolved by day 15, maintained to day 30
  • Stress: Fully resolved by day 15, maintained to day 30
  • Anxiety: No change


💪 Physical Function & Social Participation

  • Physical function: ↑ 19% by day 15, maintained through day 30
  • Ability to participate in social roles: ↑ 15%, sustained
  • Anxiety (PROMIS): ↓ 5% at day 15, ↓ 25% at day 30


⚡ Fatigue & Sleep Disturbance

  • Fatigue (PROMIS): Brief rise (+22%) mid-study, then ↓ 15% by day 30
  • Sleep disturbance: ↓ 24% at day 15, but ↑ 19% over baseline by day 30


💊 Pain Relief

  • Pain interference: ↓ 29%
  • Pain score: ↓ 43% by day 15, ↓ 57% by day 30


🧠 Autonomic & Brain Blood Flow

  • Parasympathetic activity: ↑ 10%
  • Sympathetic activity: ↓ 9%
  • Cerebral oxygenation (rCBO₂): ↑ 110%
  • Cerebral blood flow (CBF): ↓ 7%


🔋 Mitochondrial Performance Boost

  • Mitochondrial membrane potential: ↑ 305%
  • Mitochondrial efficiency: ↑ 12%
  • Mitochondrial Index: ↑ 53%
  • Network integrity: ↑ 195% (rest), ↑ 170% (stress)
  • Baseline respiration: ↑ 200%


Metabolic shifts:

  • Glycolytic score ↓ 62%
  • Aerobic score ↓ 13%


Redox changes:

  • ROS (baseline): ↑ 290%
  • ROS (stress): ↑ 213%


Key Takeaways

In just one month, M.T. experienced:

  • Dramatic pain relief and better physical function
  • Improved sleep quality and mood stability
  • Enhanced mitochondrial performance, suggesting improved cellular energy capacity

 

Link to full case report:  Read full Case Report